Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $52.25 and last traded at $52.25, with a volume of 0 shares trading hands. The stock had previously closed at $52.25.
Analyst Ratings Changes
Separately, Royal Bank of Canada upgraded shares of Recordati Industria Chimica e Farmaceutica to a “hold” rating in a research report on Monday.
Read Our Latest Stock Report on RCDTF
Recordati Industria Chimica e Farmaceutica Stock Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last announced its quarterly earnings data on Tuesday, July 30th. The company reported $0.70 earnings per share (EPS) for the quarter. The business had revenue of $622.00 million for the quarter. Recordati Industria Chimica e Farmaceutica had a net margin of 17.41% and a return on equity of 30.78%.
Recordati Industria Chimica e Farmaceutica Company Profile
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
See Also
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- How to Most Effectively Use the MarketBeat Earnings Screener
- 3 Momentum Trades for October With Ample Upside Ahead
- How to invest in marijuana stocks in 7 steps
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Stock Analyst Ratings and Canadian Analyst Ratings
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.